Death associated with hexamethonium and 1-hydrazinophthalazine (apresoline) therapy.
D002317:Cardiovascular Agents; D003643:Death; D018738:Hexamethonium; D006830:Hydralazine; D006973:Hypertension / Q000628:therapy*; D009125:Muscle Relaxants, Central / Q000009:adverse effects*; D013565:Sympatholytics / Q000009:adverse effects*
D002317:Cardiovascular Agents; D009125:Muscle Relaxants, Central; D013565:Sympatholytics; D006830:Hydralazine; D018738:Hexamethonium
HYPERTENSION/therapy; MUSCLE RELAXANTS/injurious effects; SYMPATHOLYTICS/injurious effects